… 本文对COVID-19抗病毒药物的种类及其 … Liver injury induced by COVID19treat⁃ ment - what do we know?[J]. … China’s first approved novel neutralizingantibody combination therapy …
… diseases treated with CP, and analyzed CP therapy as a potential treatment for COVID-19. … , plasma treatment, antibody titer detection, and its clinical treatment experiences in avian …
… the epidemiological characteristics of the re-positive patients in two COVID-19 outbreaks caused by Delta variant strains in Ningbo, to provide a scientific basis for better management. …
… , neutralizingantibodies, and small molecule chemical agents have effectively prevented the rapid spread of COVID-19. … therapy in treating 60 Cases of COVID-19 with syndrome of …
… antibodies in the recovered patient's plasma can neutralize … is mainly used in the treatment of COVID-19 patients with rapid … of plasma donors in COVID-19 rehabilitation period, so as to …
… COVID-19, aiming to discuss the personal protection, systemic anti-cancer therapy, outcome of co-infection, and the clinical management … neutralizingantibody response to COVID-19 …
… such as Ebola hemorrhagic fever, COVID-19 infection, and malaria have … to treat severe infectious diseases. Nanobodies are VHH domains discovered on heavy-chain antibodies found …